Filtros : "European Journal of Pharmacology" "2011" Removido: "ICB-BMB" Limpar

Filtros



Refine with date range


  • Source: European Journal of Pharmacology. Unidades: FCFRP, FMRP

    Subjects: ÓXIDO NÍTRICO, AORTA DE ANIMAL, POTÁSSIO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CELOTTO, Andréa C. et al. Acidosis induces relaxation mediated by nitric oxide and potassium channels in rat thoracic aorta. European Journal of Pharmacology, v. 656, n. 1-3, p. 88-93, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.01.053. Acesso em: 06 out. 2024.
    • APA

      Celotto, A. C., Restini, C. B. A., Capellini, V. K., Bendhack, L. M., & Evora, P. R. B. (2011). Acidosis induces relaxation mediated by nitric oxide and potassium channels in rat thoracic aorta. European Journal of Pharmacology, 656( 1-3), 88-93. doi:10.1016/j.ejphar.2011.01.053
    • NLM

      Celotto AC, Restini CBA, Capellini VK, Bendhack LM, Evora PRB. Acidosis induces relaxation mediated by nitric oxide and potassium channels in rat thoracic aorta [Internet]. European Journal of Pharmacology. 2011 ; 656( 1-3): 88-93.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.01.053
    • Vancouver

      Celotto AC, Restini CBA, Capellini VK, Bendhack LM, Evora PRB. Acidosis induces relaxation mediated by nitric oxide and potassium channels in rat thoracic aorta [Internet]. European Journal of Pharmacology. 2011 ; 656( 1-3): 88-93.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.01.053
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: CARDIOPATIAS, INSUFICIÊNCIA CARDÍACA, ANTINEOPLÁSICOS, NEOPLASIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAMPOS, Erica C. et al. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. European Journal of Pharmacology, v. 670, n. 2/3, p. 541-553, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.09.021. Acesso em: 06 out. 2024.
    • APA

      Campos, E. C., O'Connell, J. L., Malvestio, L. M., Romano, M. M. D., Ramos, S. G., Celes, M. R. N., et al. (2011). Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. European Journal of Pharmacology, 670( 2/3), 541-553. doi:10.1016/j.ejphar.2011.09.021
    • NLM

      Campos EC, O'Connell JL, Malvestio LM, Romano MMD, Ramos SG, Celes MRN, Prado CM, Simões MV, Rossi MA. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy [Internet]. European Journal of Pharmacology. 2011 ; 670( 2/3): 541-553.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.09.021
    • Vancouver

      Campos EC, O'Connell JL, Malvestio LM, Romano MMD, Ramos SG, Celes MRN, Prado CM, Simões MV, Rossi MA. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy [Internet]. European Journal of Pharmacology. 2011 ; 670( 2/3): 541-553.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.09.021
  • Source: European Journal of Pharmacology. Unidade: ICB

    Assunto: HISTOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LAVIANO, Alessandro et al. Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy?. European Journal of Pharmacology, v. 668, p. S87-S90, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.06.060. Acesso em: 06 out. 2024.
    • APA

      Laviano, A., Seelaender, M. C. L., Sanchez-Lara, K., Gioulbasanis, I., Molfino, A., & Fanelli, F. R. (2011). Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy? European Journal of Pharmacology, 668, S87-S90. doi:10.1016/j.ejphar.2011.06.060
    • NLM

      Laviano A, Seelaender MCL, Sanchez-Lara K, Gioulbasanis I, Molfino A, Fanelli FR. Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy? [Internet]. European Journal of Pharmacology. 2011 ; 668 S87-S90.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.06.060
    • Vancouver

      Laviano A, Seelaender MCL, Sanchez-Lara K, Gioulbasanis I, Molfino A, Fanelli FR. Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy? [Internet]. European Journal of Pharmacology. 2011 ; 668 S87-S90.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.06.060
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: CÉLULAS-TRONCO, GENÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      INSELMAN, Amy L. et al. Assessment of research models for testing gene-environment interactions. European Journal of Pharmacology, v. 668, p. S108-S116, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.05.084. Acesso em: 06 out. 2024.
    • APA

      Inselman, A. L., Hansen, D. K., Hyung-yul, L., Nakamura, N., Ning, B., Monteiro, J. P., et al. (2011). Assessment of research models for testing gene-environment interactions. European Journal of Pharmacology, 668, S108-S116. doi:10.1016/j.ejphar.2011.05.084
    • NLM

      Inselman AL, Hansen DK, Hyung-yul L, Nakamura N, Ning B, Monteiro JP, Varma V, Kaput J. Assessment of research models for testing gene-environment interactions [Internet]. European Journal of Pharmacology. 2011 ;668 S108-S116.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.05.084
    • Vancouver

      Inselman AL, Hansen DK, Hyung-yul L, Nakamura N, Ning B, Monteiro JP, Varma V, Kaput J. Assessment of research models for testing gene-environment interactions [Internet]. European Journal of Pharmacology. 2011 ;668 S108-S116.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.05.084
  • Source: European Journal of Pharmacology. Unidades: FMRP, FCFRP, EERP

    Subjects: FÁRMACOS SEMISSINTÉTICOS, HIPOTENSÃO, AORTA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HIPÓLITO, Ulisses V. et al. The semi-synthetic kaurane ent-16'alfa'-methoxykauran-19-oic acid induces vascular relaxation and hypotension in rats. European Journal of Pharmacology, v. 660, n. 2-3, p. 402-410, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.04.019. Acesso em: 06 out. 2024.
    • APA

      Hipólito, U. V., Rocha, J. T., Palazzin, N. B., Rodrigues, G. J., Crestani, C. C., Corrêa, F. M. de A., et al. (2011). The semi-synthetic kaurane ent-16'alfa'-methoxykauran-19-oic acid induces vascular relaxation and hypotension in rats. European Journal of Pharmacology, 660( 2-3), 402-410. doi:10.1016/j.ejphar.2011.04.019
    • NLM

      Hipólito UV, Rocha JT, Palazzin NB, Rodrigues GJ, Crestani CC, Corrêa FM de A, Bonaventura D, Ambrosio SR, Bendhack LM, Resstel LBM, Tirapelli CR. The semi-synthetic kaurane ent-16'alfa'-methoxykauran-19-oic acid induces vascular relaxation and hypotension in rats [Internet]. European Journal of Pharmacology. 2011 ; 660( 2-3): 402-410.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.04.019
    • Vancouver

      Hipólito UV, Rocha JT, Palazzin NB, Rodrigues GJ, Crestani CC, Corrêa FM de A, Bonaventura D, Ambrosio SR, Bendhack LM, Resstel LBM, Tirapelli CR. The semi-synthetic kaurane ent-16'alfa'-methoxykauran-19-oic acid induces vascular relaxation and hypotension in rats [Internet]. European Journal of Pharmacology. 2011 ; 660( 2-3): 402-410.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.04.019
  • Source: European Journal of Pharmacology. Unidade: ICB

    Assunto: IMUNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMEIDA, Ana Carolina de et al. 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis. European Journal of Pharmacology, v. 660, n. 2-3, p. 445-453, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2011.03.043. Acesso em: 06 out. 2024.
    • APA

      Almeida, A. C. de, Marques, O. C., Arslanian, C., Condino-Neto, A., & Ximenes, V. F. (2011). 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis. European Journal of Pharmacology, 660( 2-3), 445-453. doi:10.1016/j.ejphar.2011.03.043
    • NLM

      Almeida AC de, Marques OC, Arslanian C, Condino-Neto A, Ximenes VF. 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis [Internet]. European Journal of Pharmacology. 2011 ; 660( 2-3): 445-453.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.03.043
    • Vancouver

      Almeida AC de, Marques OC, Arslanian C, Condino-Neto A, Ximenes VF. 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis [Internet]. European Journal of Pharmacology. 2011 ; 660( 2-3): 445-453.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.ejphar.2011.03.043

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024